A novel approach to generating morbillivirus vaccines: Negatively marking the rinderpest vaccine

Vaccine

Volumn 30, Issue 11, 2012, Pages 1927-1935

  Buczkowski, Hubert ^a,b   Parida, Satya ^a   Bailey, Dalan ^a,c   Barrett, Thomas ^a   Banyard, Ashley C ^a,b  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

C1 mAb; DIVA vaccine; Epitope mapping; Haemagglutinin; Rinderpest

Indexed keywords

C1 MONOCLONAL ANTIBODY; EPITOPE; MEASLES VACCINE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

ARTICLE; CATTLE PLAGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PROCEDURES; HUMAN; IMMUNODIFFUSION; IN VITRO STUDY; MEASLES VIRUS; MUTANT; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; CERCOPITHECUS AETHIOPS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HEMAGGLUTININS, VIRAL; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE LIBRARY; PESTE-DES-PETITS-RUMINANTS; PESTE-DES-PETITS-RUMINANTS VIRUS; PROTEIN STRUCTURE, TERTIARY; RINDERPEST; RINDERPEST VIRUS; VACCINES, DNA; VERO CELLS; VIRAL VACCINES;

EID: 84857189043     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.029     Document Type: Article

References (41)

1. Barrett T., Banyard A.C., Diallo A. Molecular biology of the morbilliviruses. Rinderpest and peste des petits ruminants. Virus plagues of large and small ruminants 2006, 31-67. Academic Press. T. Barrett, P.-P. Pastoret, W.P. Taylor (Eds.).
2. Plowright W. The application of monolayer tissue culture techniques in rinderpest research. II. The use of attenuated culture virus as a vaccine for cattle. Bull Off Int Epizoot 1962, 57.
3. Anderson J., McKay J.A. The detection of antibodies against peste des petits ruminants virus in cattle, sheep and goats and the possible implications to rinderpest control programmes. Epidemiol Infect 1994, 112(February (1)):225-231.
4. Rweyemamu M.M., Cheneau Y. Strategy for the global rinderpest eradication programme. Vet Microbiol 1995, 44(May (2-4)):369-376.
5. Walsh E.P., Baron M.D., Anderson J., Barrett T. Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein. J Gen Virol 2000, 81(March (Pt 3)):709-718.
6. Walsh E.P., Baron M.D., Rennie L.F., Monaghan P., Anderson J., Barrett T. Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope. J Virol 2000, 74(November (21)):10165-10175.
7. Das S.C., Baron M.D., Barrett T. Recovery and characterization of a chimeric rinderpest virus with the glycoproteins of peste-des-petits-ruminants virus: homologous F and H proteins are required for virus viability. J Virol 2000, 74(October (19)):9039-9047.
8. Mahapatra M., Parida S., Baron M.D., Barrett T. Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex. J Gen Virol 2006, 87(July (Pt 7)):2021-2029.
9. Parida S., Mahapatra M., Kumar S., Das S.C., Baron M.D., Anderson J., et al. Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J Gen Virol 2007, 88(July (Pt 7)):2019-2027.
10. Peeters B.P., de Leeuw O.S., Verstegen I., Koch G., Gielkens A.L. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine 2001, 19(February (13-14)):1616-1627.
11. Wehrle F., Renzullo S., Faust A., Beer M., Kaden V., Hofmann M.A. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines. J Gen Virol 2007, 88(August (Pt 8)):2247-2258.
12. Seki F., Ono N., Yamaguchi R., Yanagi Y. Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J Virol 2003, 77(September (18)):9943-9950.
13. Baron M.D., Barrett T. Rescue of rinderpest virus from cloned cDNA. J Virol 1997, 71(February (2)):1265-1271.
14. Baron M.D., Foster-Cuevas M., Baron J., Barrett T. Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus. J Gen Virol 1999, 80(August (Pt 8)):2031-2039.
15. Anderson J., Rowe L.W. Application of enzyme immuno-assays in rinderpest research. The ELISA: enzyme-linked immunosorbent assay in veterinary research and diagnosis; proceedings of a meeting held at the University of Surrey, September 15-17 1981, 176-191. Guildford, U.K. R.C. Wardley, J.R. Crowther (Eds.).
16. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18(December (15)):2714-2723.
17. Masse N., Ainouze M., Neel B., Wild T.F., Buckland R., Langedijk J.P. Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol 2004, 78(September (17)):9051-9063.
18. Baron M.D., Barrett T. Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J Virol 2000, 74(March (6)):2603-2611.
19. Das S.C., Baron M.D., Skinner M.A., Barrett T. Improved technique for transient expression and negative strand virus rescue using fowlpox T7 recombinant virus in mammalian cells. J Virol Methods 2000, 89(September (1-2)):119-127.
20. Banyard A.C., Simpson J., Monaghan P., Barrett T. Rinderpest virus expressing enhanced green fluorescent protein as a separate transcription unit retains pathogenicity for cattle. J Gen Virol 2010, 91(December (Pt 12)):2918-2927.
21. Anderson J., Barrett T., Scott G.R. Manual on the diagnosis of rinderpest 1996, FAO, Rome, p. 143.
22. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938, 27:493-497.
23. Langedijk J.P., Daus F.J., van Oirschot J.T. Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol 1997, 71(August (8)):6155-6167.
24. Seth S., Shaila M.S. The fusion protein of Peste des petits ruminants virus mediates biological fusion in the absence of hemagglutinin-neuraminidase protein. Virology 2001, 289(October (1)):86-94.
25. Stegeman A., Van Oirschot J.T., Kimman T.G., Tielen M.J., Hunneman W.A., Berndsen F.W. Reduction of the prevalence of pseudorabies virus-infected breeding pigs by use of intensive regional vaccination. Am J Vet Res 1994, 55(October (10)):1381-1385.
26. Stegeman J.A., Tielen M.J., Kimman T.G., Van Oirschot J.T., Hunneman W.A., Berndsen F.W. Intensive regional vaccination with a gI-deleted vaccine markedly reduces pseudorabies virus infections. Vaccine 1994, 12(May (6)):527-531.
27. van Engelenburg F.A., Kaashoek M.J., Rijsewijk F.A., van den Burg L., Moerman A., Gielkens A.L., et al. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J Gen Virol 1994, 75(September (Pt 9)):2311-2318.
28. Sugiyama M., Ito N., Minamoto N., Tanaka S. Identification of immunodominant neutralizing epitopes on the hemagglutinin protein of rinderpest virus. J Virol 2002, 76(February (4)):1691-1696.
29. Baron M.D. Wild-type Rinderpest virus uses SLAM (CD150) as its receptor. J Gen Virol 2005, 86(June (Pt 6)):1753-1757.
30. Tatsuo H., Ono N., Yanagi Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J Virol 2001, 75(July (13)):5842-5850.
31. Tatsuo H., Yanagi Y. The morbillivirus receptor SLAM (CD150). Microbiol Immunol 2002, 46(3):135-142.
32. Hu C., Zhang P., Liu X., Qi Y., Zou T., Xu Q. Characterization of a region involved in binding of measles virus H protein and its receptor SLAM (CD150). Biochem Biophys Res Commun 2004, 316(April (3)):698-704.
33. Guillaume V., Aslan H., Ainouze M., Guerbois M., Wild T.F., Buckland R., et al. Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model. J Virol 2006, 80(August (15)):7546-7554.
34. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., et al. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science 1988, 242(November (4881)):1058-1061.
35. Bansal R.P., Chawla S.K., Joshi R.C., Shukla D.C. Studies on attenuated rinderpest vaccine of tissue culture origin. Ind J Anim Sci 1974, 44:520-524.
36. Johnson R.H. Rinderpest in tissue culture. III. Use of the attenuated strain as a vaccine for cattle. Br Vet J 1962, 118:141-150.
37. Normile D. Animal science. Rinderpest, deadly for cattle, joins smallpox as a vanquished disease. Science 2010, 330(October (6003)):435.
38. Diallo A. Control of peste des petits ruminants: classical and new generation vaccines. Dev Biol (Basel) 2003, 114:113-119.
39. Saravanan P., Sen A., Balamurugan V., Rajak K.K., Bhanuprakash V., Palaniswami K.S., et al. Comparative efficacy of peste des petits ruminants (PPR) vaccines. Biologicals 2010, 38(July (4)):479-485.
40. Banyard A.C., Parida S., Batten C., Oura C., Kwiatek O., Libeau G. Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control. J Gen Virol 2010, 91(December (Pt 12)):2885-2897.
41. van Oirschot J.T. Diva vaccines that reduce virus transmission. J Biotechnol 1999, 73(August (2-3)):195-205.